Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data

American Journal of Epidemiology

Volumn 154, Issue 9, 2001, Pages 854-864

  Schneeweiss, Sebastian ^a,b   Seeger, John D ^b   Maclure, Malcolm ^b,c   Wang, Philip S ^a,b   Avorn, Jerry ^a   Glynn, Robert J ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c MINISTRY OF HEALTH   (Canada)

Author keywords

Comorbidity; Confounding factors (epidemiology); Databases; Epidemiologic studies; Health services

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

EPIDEMIOLOGY; MORBIDITY;

AGED; ARTICLE; CHRONIC DISEASE; COMORBIDITY; CONTROLLED STUDY; DATA BASE; DEATH; ELDERLY CARE; EPIDEMIOLOGICAL DATA; FEMALE; FOLLOW UP; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH SERVICE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; MORTALITY; PERFORMANCE; PHYSICIAN; PREDICTION; RACE; STATISTICAL ANALYSIS;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; COHORT STUDIES; COMORBIDITY; CONFOUNDING FACTORS (EPIDEMIOLOGY); EMERGENCY SERVICE, HOSPITAL; EPIDEMIOLOGIC STUDIES; FEMALE; HEALTH EXPENDITURES; HUMANS; HYPERTENSION; INSURANCE CLAIM REVIEW; LOGISTIC MODELS; LONG-TERM CARE; MALE; MODELS, STATISTICAL; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT ADMISSION; PREDICTIVE VALUE OF TESTS;

EID: 0035500992     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/154.9.854     Document Type: Article

References (42)

1. Use of comorbidity scores for control of confounding in studies using administrative databases
2. Recent developments and future issues in the use of health status assessment measures in clinical settings
3. Risk adjustment in claims-based research: The search for efficient approaches
4. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: Differing perspectives
5. Further evidence concerning the use of a clinical comorbidity index with ICD-9-CM administrative data
6. A chronic disease score from automated pharmacy data
7. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
8. Risk adjustment in outcome assessment: The Charlson comorbidity index
9. Practical considerations on the use of the Charlson index with administrative data bases
10. Searching for an improved clinical comorbidity index for use with ICD-9-CM administrative data
11. Selecting a patient characteristics index for the prediction of medical outcomes using administrative claims data
12. Controlling for confounding by indication for treatment. Are administrative data equivalent to clinical data?
13. A chronic disease score with empirically derived weights
14. Intended and unintended impacts on antihypertensive drug use by a policy of differential cost sharing for angiotensin-converting enzyme inhibitors
15. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
16. Validation of a combined comorbidity index
17. Methods for analyzing health care utilization and costs
18. Trends and determinants of prescription drug expenditures in the elderly: Data from the British Columbia Pharmacare Program
19. Agreement between physicians' office records and medicare Part B claims data
20. Bias in the coding of hospital discharge data and its implications for quality assessment
21. Agreement between drug treatment data and a discharge diagnosis of diabetes mellitus in the elderly
22. The accuracy of Medicare's hospital claims data: Progress has been made but problems remain
23. Evaluating the performance of risk-adjustment methods: Dichotomous outcomes
24. Prediction of coronary heart disease using risk factor categories
25. Evaluating the performance of risk-adjustment methods: Continuous outcomes
26. Comparison of analytic models for estimating the effect of clinical factors on the cost of coronary bypass graft surgery
27. Aging, comorbidity, and reduced rates of drug treatment for diabetes mellitus
28. The treatment of unrelated disorders in patients with chronic medical diseases
29. The performance of different lookback periods and sources of information for Charlson comorbidity adjustment in Medicare claims
30. Strategies for improving comorbidity measures based on Medicare and Medicaid claims data
31. Complications, comorbidities, and mortality: Improving classification and prediction
32. Clinical versus administrative data bases for CABG surgery. Does it matter?
33. Identifying adults at increased risk of coronary disease: How well do the current cholesterol guidelines work?
34. Does body mass index adequately capture the relation of body composition and body size to health outcomes?
35. How well do prediction equations predict? Using receiver operating characteristic curves and accuracy curves to compare validity and generalizability